Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological Investigations of the Dissociative ‘Legal Highs’ Diphenidine, Methoxphenidine and Analogues
Jason Wallach, Heather Kang, Tristan Colestock, et al.
PLoS ONE (2016) Vol. 11, Iss. 6, pp. e0157021-e0157021
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Panos Zanos, Ruin Moaddel, Patrick J. Morris, et al.
Pharmacological Reviews (2018) Vol. 70, Iss. 3, pp. 621-660
Open Access | Times Cited: 938
New psychoactive substances: a review and updates
Abu Shafi, Alex J. Berry, Harry Sumnall, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 241
Designer drugs: mechanism of action and adverse effects
Dino Luethi, Matthias E. Liechti
Archives of Toxicology (2020) Vol. 94, Iss. 4, pp. 1085-1133
Open Access | Times Cited: 210
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review
Barry K. Logan, Amanda L A Mohr, Melissa Friscia, et al.
Journal of Analytical Toxicology (2017) Vol. 41, Iss. 7, pp. 573-610
Open Access | Times Cited: 148
Tertiary amine synthesis via reductive coupling of amides with Grignard reagents
Lan‐Gui Xie, Darren J. Dixon
Chemical Science (2017) Vol. 8, Iss. 11, pp. 7492-7497
Open Access | Times Cited: 113
New/emerging psychoactive substances and associated psychopathological consequences
Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini, et al.
Psychological Medicine (2019) Vol. 51, Iss. 1, pp. 30-42
Open Access | Times Cited: 93
Advantages and Limitations of Animal Schizophrenia Models
Magdalena Białoń, Agnieszka Wąsik
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5968-5968
Open Access | Times Cited: 67
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review
Amanda L A Mohr, Barry K. Logan, Melissa F. Fogarty, et al.
Journal of Analytical Toxicology (2022) Vol. 46, Iss. 6, pp. e116-e185
Open Access | Times Cited: 44
Fatal intoxication by 5F–ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q‐TOFMS
Maiko Kusano, Kei Zaitsu, Kentaro Taki, et al.
Drug Testing and Analysis (2017) Vol. 10, Iss. 2, pp. 284-293
Open Access | Times Cited: 68
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review
Fabrizio Schifano, Stefania Chiappini, Andrea Miuli, et al.
Experimental Neurology (2021) Vol. 339, pp. 113638-113638
Open Access | Times Cited: 41
Prefrontal and Hippocampal Parvalbumin Interneurons in Animal Models for Schizophrenia: A Systematic Review and Meta-analysis
Thamyris Santos‐Silva, Débora dos Santos Fabris, Cilene Lino de Oliveira, et al.
Schizophrenia Bulletin (2023) Vol. 50, Iss. 1, pp. 210-223
Open Access | Times Cited: 16
An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions
Vern Lewis, Gareth M. Rurak, Natalina Salmaso, et al.
Trends in Neurosciences (2024) Vol. 47, Iss. 3, pp. 195-208
Open Access | Times Cited: 7
Identification of three unexpected new psychoactive substances at an Australian drug checking service
Jess L. Algar, Douglas J. Lawes, Adam J. Carroll, et al.
Drug Testing and Analysis (2024) Vol. 16, Iss. 10, pp. 1144-1154
Open Access | Times Cited: 6
Guilty by Dissociation: Part C: Enantiomeric Separation of Diphenidine-Derived New Psychoactive Substances (NPS) by Polar Organic Chiral High Performance Liquid Chromatography (HPLC) on Polysaccharide-Based Stationary Phases
Melvin R. Euerby, B. Barrett, Andrew Costello, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 258, pp. 116728-116728
Closed Access
The acute effects of methoxphenidine on behaviour and pharmacokinetics profile in animal model
Kristýna Štefková, Hynek Danda, Vladimír Mazoch, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025) Vol. 137, pp. 111285-111285
Closed Access
Synthesis and crystal structures of five fluorinated diphenidine derivatives
Ryan E. Mewis, Matthew C. Hulme, Jack Marron, et al.
Acta Crystallographica Section E Crystallographic Communications (2025) Vol. 81, Iss. 3, pp. 229-234
Open Access
Assessing the toxicological significance of new psychoactive substances in fatalities
Simon Elliott, Roumen Sedefov, Michael Evans‐Brown
Drug Testing and Analysis (2017) Vol. 10, Iss. 1, pp. 120-126
Open Access | Times Cited: 44
Fatal Poisonings Associated with New Psychoactive Substances
Robert Kronstrand, Davide Guerrieri, Svante Vikingsson, et al.
Handbook of experimental pharmacology (2018), pp. 495-541
Closed Access | Times Cited: 43
(R)‐ and (S)‐ketamine induce differential fMRI responses in conscious rats
Yukiko Masaki, Yuto Kashiwagi, Hiroshi Watabe, et al.
Synapse (2019) Vol. 73, Iss. 12
Closed Access | Times Cited: 35
New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions
Chinaza Godswill Awuchi, Patrick Maduabuchi Aja, Nancy Bonareri Mitaki, et al.
Journal of Chemistry (2023) Vol. 2023, pp. 1-36
Open Access | Times Cited: 11
Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems
Dino Luethi, Marius C. Hoener, Matthias E. Liechti
European Journal of Pharmacology (2017) Vol. 819, pp. 242-247
Closed Access | Times Cited: 37
Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity
Rachael Ingram, Heather Kang, Stafford L. Lightman, et al.
Neuropharmacology (2018) Vol. 142, pp. 30-40
Open Access | Times Cited: 33
The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity
Predrag Sikirić, Alenka Boban Blagaić, Sanja Štrbe, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 461-461
Open Access | Times Cited: 3
1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances
Jason Wallach, Simon D. Brandt
Handbook of experimental pharmacology (2018), pp. 305-352
Closed Access | Times Cited: 31
Phencyclidine-Based New Psychoactive Substances
Jason Wallach, Simon D. Brandt
Handbook of experimental pharmacology (2018), pp. 261-303
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top